Bharat Biotech fast-tracks Covaxin trials; Russia approves second vaccine : News Reel: Business Today
Business Today
Loading...
 

Bharat Biotech fast-tracks Covaxin trials; Russia approves second vaccine

BusinessToday.In | October 15, 2020

As part of its effort to fast-track COVID-19 vaccine development, Hyderabad-based Bharat Biotech has cut the size of Phase 2 clinical trials of its indigenous coronavirus vaccine Covaxin by half; Bicycle sales in India have grown by over two-folds in the last five months as people are opting for this cheapest mode of transport to cover short to medium distance; Russia on Wednesday announced that it has granted regulatory approval to another COVID-19 vaccine named EpiVacCorona. Watch this and more on News Blast.

Also Read: Need to develop more disease-specific health insurance policies: IRDAI



    More from this section